NRX Pharmaceuticals
Earnings Surprise
Analysts estimated NRXP earnings of $-0.00 per share this quarter (Q4). NRXP's actual earnings were $-0.01 per share.
NRXP EPS surprise of -361.54%Analysts estimated NRXP earnings of $-0.09 per share this quarter (Q3). NRXP's actual earnings were $-0.50 per share.
NRXP EPS surprise of -476.70%Analysts estimated NRXP earnings of $-0.21 per share this quarter (Q2). NRXP's actual earnings were $-0.31 per share.
NRXP EPS surprise of -49.47%Analysts estimated NRXP earnings of $-0.31 per share this quarter (Q1). NRXP's actual earnings were $-0.21 per share.
NRXP EPS surprise of 31.37%Analysts estimated NRXP earnings of $-0.32 per share this quarter (Q4). NRXP's actual earnings were $-0.77 per share.
NRXP EPS surprise of -138.39%Analysts estimated NRXP earnings of $-0.65 per share this quarter (Q3). NRXP's actual earnings were $-0.13 per share.
NRXP EPS surprise of 80.09%Analysts estimated NRXP earnings of $-0.71 per share this quarter (Q2). NRXP's actual earnings were $-0.67 per share.
NRXP EPS surprise of 5.49%Analysts estimated NRXP earnings of $-0.56 per share this quarter (Q1). NRXP's actual earnings were $-0.74 per share.
NRXP EPS surprise of -31.91%Analysts estimated NRXP earnings of $-0.71 per share this quarter (Q4). NRXP's actual earnings were $-5.37 per share.
NRXP EPS surprise of 652.10%Analysts estimated NRXP earnings of $-0.12 per share this quarter (Q3). NRXP's actual earnings were $-0.07 per share.
NRXP EPS surprise of -39.45%